INSR, a protein essential for insulin activity, plays a critical role in stem cell longevity. Additionally, inactivating INSR in glioblastoma brain cancer stem cells inhibits the growth of primitive tumor forming cells.
Study found no increased risk of developing brain tumors regardless of whether a person was a frequent cell phone user or if they had never used a cell phone before.
Researchers are currently recruiting patients for a Phase 1 trial of a new immunotherapy treatment for glioblastoma brain cancer.
Researchers have identified a potential new target to treat breast cancer that has spread to the brain using existing drugs.
Inhibition of the OR5B21 olfactory receptor gene significantly decreased the metastasis of breast cancer cells to the brain, lungs, and bones, researchers report.
Asthma causes T cells to induce lung inflammation but prevents the growth of brain tumors. Reprogramming T cells in patients with brain cancer to act like T cells in those with asthma may help to curb the growth of tumors.
A class of drugs called BACE1 inhibitors, originally designed to treat Alzheimer's disease, shows potential for the treatment of glioblastoma brain cancer.
Combining Disulfiram, a medication commonly used to treat chronic alcoholism, with copper ions kills medulloblastoma cancer cells and prevents new ones from growing.
Variations in the TSPO neuroinflammation-associated protein's structure correlates with worse survival outcomes for male glioblastoma brain cancer patients than females.
A combination of approved and novel therapeutics improved survival rates and reduced both tumor volume and growth for those suffering from glioblastoma brain cancer.
Cellular reprogramming of glioma cells into neural cells may be a promising treatment for glioblastoma brain cancer.
A newly identified gene therapy pathway has the potential to protect us against dementia and cancer, researchers report.
